Male breast cancer

[1]  D. Howlett,et al.  Male breast carcinoma and the use of MRI , 2015, Radiology case reports.

[2]  Y. Hotko.  Male breast cancer: clinical presentation, diagnosis, treatment. , 2013, Experimental oncology.

[3]  J. Steel,et al.  Imaging male breast cancer. , 2011, Clinical radiology.

[4]  K. Czene,et al.  Incidence and outcome of male breast cancer: an international population-based study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Jongphil Kim,et al.  Male Breast Cancer: Management and Follow‐up Recommendations , 2011, The breast journal.

[6]  S. Merajver,et al.  Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients , 2011, Breast Cancer Research and Treatment.

[7]  K. J. Johansen Taber,et al.  Male breast cancer: risk factors, diagnosis, and management (Review). , 2010, Oncology reports.

[8]  L. Ottini,et al.  HER2-positive male breast cancer: an update. , 2010, Breast cancer.

[9]  E. Casado,et al.  Male breast cancer. , 2010, Cancer treatment reviews.

[10]  A. Italiano,et al.  Aromatase inhibition in male breast cancer patients: biological and clinical implications. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Bergh,et al.  Multidisciplinary meeting on male breast cancer: summary and research recommendations. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Pal,et al.  Male breast cancer: an update in diagnosis, treatment and molecular profiling. , 2010, Maturitas.

[13]  F. Penault-Llorca,et al.  Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. , 2010, Critical reviews in oncology/hematology.

[14]  D. Palli,et al.  Male breast cancer. , 2010, Critical reviews in oncology/hematology.

[15]  Philip S Rosenberg,et al.  Male breast cancer: a population-based comparison with female breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  I. Fentiman.  Male breast cancer: a review , 2009, Ecancermedicalscience.

[17]  F. Marchal,et al.  Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women , 2009, Annals of Surgical Oncology.

[18]  Janet M. Gray,et al.  State of the Evidence: The Connection Between Breast Cancer and the Environment , 2009, International journal of occupational and environmental health.

[19]  D. Dalley,et al.  Breast Cancer in Men—Should Aromatase Inhibitors Become First‐Line Hormonal Treatment? , 2008, The breast journal.

[20]  Gretchen L. Gierach,et al.  Prospective evaluation of risk factors for male breast cancer. , 2008, Journal of the National Cancer Institute.

[21]  D. Hadjiminas,et al.  Diagnosis and Management of Male Breast Cancer , 2008, World Journal of Surgery.

[22]  H. Singhal,et al.  Male breast cancer: is the scenario changing , 2008, World journal of surgical oncology.

[23]  L. Shavit,et al.  Second cancers in patients with male breast cancer: a literature review , 2008, Journal of cancer survivorship : research and practice.

[24]  Giovanni Parmigiani,et al.  Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. , 2007, Journal of the National Cancer Institute.

[25]  J. Robertson,et al.  Male breast cancer: a review of clinical management , 2007, Breast Cancer Research and Treatment.

[26]  A. Jazieh,et al.  Male breast cancer in the veterans affairs population , 2007, Cancer.

[27]  M. Ross,et al.  Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. , 2006, Journal of the American College of Surgeons.

[28]  Z. Nahleh,et al.  Male breast cancer: a gender issue , 2006, Nature Clinical Practice Oncology.

[29]  G. Hortobagyi,et al.  Leuprolide acetate plus aromatase inhibition for male breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  L. Bassett,et al.  Imaging characteristics of malignant lesions of the male breast. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[31]  L. Wilkens,et al.  Comparative Epidemiology of Breast Cancer Among Men and Women in the US, 1996 to 2000 , 2006, Cancer Causes & Control.

[32]  A. Swerdlow,et al.  Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. , 2005, Journal of the National Cancer Institute.

[33]  S. Giordano.  A review of the diagnosis and management of male breast cancer. , 2005, The oncologist.

[34]  D. Preston,et al.  Male breast cancer incidence among atomic bomb survivors. , 2005, Journal of the National Cancer Institute.

[35]  Helen Swede,et al.  Epidemiology of male breast cancer. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  A. Troxel,et al.  Men with breast cancer have better disease-specific survival than women. , 2004, Archives of surgery.

[37]  G. Hortobagyi,et al.  Breast carcinoma in men , 2004, Cancer.

[38]  L. Newman,et al.  Efficacy of sentinel lymph node biopsy in male breast cancer , 2004, Journal of surgical oncology.

[39]  A. Luini,et al.  Male breast cancer: a special therapeutic problem. Anything new? (Review). , 2004, International journal of oncology.

[40]  A. Auvinen,et al.  CHEK2 1100delC is not a risk factor for male breast cancer population , 2004, International journal of cancer.

[41]  E. Friedman,et al.  CHEK2*1100delC and male breast cancer risk in Israel , 2004, International journal of cancer.

[42]  D. Easton,et al.  Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers , 2004, International journal of cancer.

[43]  I. Fentiman,et al.  19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT , 2002, International journal of clinical practice.

[44]  G. Hortobagyi,et al.  Breast Cancer in Men , 2002, Annals of Internal Medicine.

[45]  A. Auvinen,et al.  Risk of subsequent cancer following breast cancer in men. , 2002, Journal of the National Cancer Institute.

[46]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[47]  O. Olopade,et al.  Male breast cancer in Cowden syndrome patients with germlinePTEN mutations , 2001, Journal of medical genetics.

[48]  H. Olsson.  Estrogen Receptor Content in Malignant Breast Tumors in Men—a Review , 2000, Journal of Mammary Gland Biology and Neoplasia.

[49]  D. Winchester,et al.  An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. , 1999, Surgery.

[50]  P. Goss,et al.  Male breast carcinoma , 1999, Cancer.

[51]  G. Hortobagyi,et al.  Male breast cancer , 1998, The Lancet.

[52]  M Dosemeci,et al.  Case-control study of occupational exposures and male breast cancer. , 1998, Occupational and environmental medicine.

[53]  P. Redlich,et al.  Carcinoma of the breast in males , 1998, Cancer.

[54]  T. Hayes,et al.  Male breast cancer: a review of the literature. , 1998, European journal of cancer.

[55]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[56]  C. Eng.  Genetics of Cowden syndrome: through the looking glass of oncology. , 1998, International journal of oncology.

[57]  J. Olsen,et al.  Risk of Breast Cancer in Men With Liver Cirrhosis , 1998, American Journal of Gastroenterology.

[58]  R. Hultborn,et al.  Prevalence of Klinefelter's syndrome in male breast cancer patients. , 1997, Anticancer research.

[59]  M. Nelen,et al.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.

[60]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[61]  J. Eyfjörd,et al.  Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.

[62]  B. Ponder,et al.  Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. , 1997, American journal of human genetics.

[63]  G. Ribeiro,et al.  A review of the management of the male breast carcinoma based on an analysis of 420 treated cases , 1996 .

[64]  P. Redlich,et al.  Breast cancer in men. , 1996, The Surgical clinics of North America.

[65]  L. Wold,et al.  A 50-year experience of male breast cancer: is outcome changing? , 1993, Surgical oncology.

[66]  A. Buzdar,et al.  Carcinoma of the Male Breast , 1992, Annals of Internal Medicine.

[67]  G. Ribeiro,et al.  Adjuvant tamoxifen for male breast cancer (MBC). , 1992, British Journal of Cancer.

[68]  G. Hortobagyi,et al.  Role of adjuvant chemotherapy in male breast cancer , 1989, Cancer.

[69]  J. Fraumeni,et al.  Occupational risks for male breast cancer in Sweden. , 1988, British journal of industrial medicine.

[70]  M. Lippman,et al.  Adjuvant Chemotherapy in Males with Cancer of the Breast , 1987, American journal of clinical oncology.

[71]  K. Mabuchi,et al.  Risk factors for male breast cancer. , 1985, Journal of the National Cancer Institute.

[72]  Doyle Ja,et al.  Cowden's disease (multiple hamartoma syndrome). , 1981 .

[73]  D. Schottenfeld,et al.  Male Breast Cancer: A Clinicopathologic Study of 97 Cases , 1978, Annals of surgery.

[74]  A. Auvinen,et al.  Androgen Receptor Gene Alterations in Finnish Male Breast Cancer , 2004, Breast Cancer Research and Treatment.

[75]  E. Gamelin,et al.  Ductal carcinoma in situ of the male breast. Analysis of 31 cases. , 1997, European journal of cancer.

[76]  S. Andreola,et al.  Prognosis of breast cancer in males: an analysis of 170 cases. , 1994, European journal of cancer.